The Acinetobacter baurnannn oxymoron: commensal hospital dweller turned pan-drug-resistant menace

被引:274
作者
Roca, Ignasi
Espinal, Paula
Vila-Farres, Xavier
Vila, Jordi
机构
[1] Hosp Clin Univ Barcelona, Dept Clin Microbiol, Sch Med, IDIBAPS, Barcelona, Spain
[2] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain
关键词
Acinetobacter baumannii; antimicrobial resistance; pathogenesis; biofilm; antimicrobial peptides; METALLO-BETA-LACTAMASE; OUTER-MEMBRANE PROTEIN; IN-VITRO ACTIVITY; HYDROLYZING OXACILLINASE OXA-58; PENICILLIN-BINDING PROTEINS; MULTIDRUG EFFLUX PUMP; GENOTYPICALLY DIVERSE COLLECTION; BAUMANNII CLINICAL STRAINS; INTENSIVE-CARE UNITS; EUROPEAN CLONE I;
D O I
10.3389/fmicb.2012.00148
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During the past few decades Acinetobacter baumannii has evolved from being a commensal dweller of health-care facilities to constitute one of the most annoying pathogens responsible for hospitalary outbreaks and it is currently considered one of the most important nosocomial pathogens. In a prevalence study of infections in intensive care units conducted among 75 countries of the five continents, this microorganism was found to be the fifth most common pathogen. Two main features contribute to the success of A. baumannii: (i) A. baumannii exhibits an outstanding ability to accumulate a great variety of resistance mechanisms acquired by different mechanisms, either mutations or acquisition of genetic elements such as plasmids, integrons, transposons, or resistant islands, making this microorganism multi- or pan-drug-resistant and (ii) The ability to survive in the environment during prolonged periods of time which, combined with its innate resistance to desiccation and disinfectants, makes A. baumannii almost impossible to eradicate from the clinical setting. In addition, its ability to produce biofilm greatly contributes to both persistence and resistance. In this review, the pathogenesis of the infections caused by this microorganism as well as the molecular bases of antibacterial resistance and clinical aspects such as treatment and potential future therapeutic strategies are discussed in depth
引用
收藏
页数:30
相关论文
共 355 条
  • [1] Acosta J, 2011, EMERG INFECT DIS, V17, P1064, DOI [10.3201/eid1706.091866, 10.3201/eid/1706.091866]
  • [2] Genomewide Analysis of Divergence of Antibiotic Resistance Determinants in Closely Related Isolates of Acinetobacter baumannii
    Adams, Mark D.
    Chan, E. Ricky
    Molyneaux, Neil D.
    Bonomo, Robert A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) : 3569 - 3577
  • [3] Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
    Adams, Mark D.
    Nickel, Gabrielle C.
    Bajaksouzian, Saralee
    Lavender, Heather
    Murthy, A. Rekha
    Jacobs, Michael R.
    Bonomo, Robert A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 3628 - 3634
  • [4] Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
    Adams, Mark D.
    Goglin, Karrie
    Molyneaux, Neil
    Hujer, Kristine M.
    Lavender, Heather
    Jamison, Jennifer J.
    MacDonald, Ian J.
    Martin, Kristienna M.
    Russo, Thomas
    Campagnari, Anthony A.
    Hujer, Andrea M.
    Bonomo, Robert A.
    Gill, Steven R.
    [J]. JOURNAL OF BACTERIOLOGY, 2008, 190 (24) : 8053 - 8064
  • [5] Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania
    Adams-Haduch, Jennifer M.
    Paterson, David L.
    Sidjabat, Hanna E.
    Pasculle, Anthony W.
    Potoski, Brian A.
    Muto, Carlene A.
    Harrison, Lee H.
    Doi, Yohei
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 3837 - 3843
  • [6] Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States
    Adams-Haduch, Jennifer M.
    Onuoha, Ezenwa O.
    Bogdanovich, Tatiana
    Tian, Guo-Bao
    Marschall, Jonas
    Urban, Carl M.
    Spellberg, Brad J.
    Rhee, Diane
    Halstead, Diane C.
    Pasculle, Anthony W.
    Doi, Yohei
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (11) : 3849 - 3854
  • [7] Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii
    Afzal-Shah, M
    Woodford, N
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 583 - 588
  • [8] Widespread transfer of resistance genes between bacterial species in an intensive care unit: Implications for hospital epidemiology
    Al Naiemi, N
    Duim, B
    Savelkoul, PHM
    Spanjaard, L
    de Jonge, E
    Bart, A
    Vandenbroucke-Grauls, CA
    de Jong, MD
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4862 - 4864
  • [9] Emergence of Tigecycline and Colistin Resistance in Acinetobacter Species Isolated from Patients in Kuwait Hospitals
    Al-Sweih, N. A.
    Al-Hubail, M. A.
    Rotimi, V. O.
    [J]. JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) : 13 - 16